Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention.

Sampietro ML, Trompet S, Verschuren JJ, Talens RP, Deelen J, Heijmans BT, de Winter RJ, Tio RA, Doevendans PA, Ganesh SK, Nabel EG, Westra HJ, Franke L, van den Akker EB, Westendorp RG, Zwinderman AH, Kastrati A, Koch W, Slagboom PE, de Knijff P, Jukema JW.

Hum Mol Genet. 2011 Dec 1;20(23):4748-57. doi: 10.1093/hmg/ddr389. Epub 2011 Aug 30.

2.

Matrix metalloproteinases 2 and 3 gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention: Is there still room for determining genetic variation of MMPs for assessment of an increased risk of restenosis?

Verschuren JJ, Sampietro ML, Pons D, Trompet S, Ewing MM, Quax PH, de Knijff P, Zwinderman AH, de Winter RJ, Tio RA, de Maat MP, Doevendans PA, Jukema JW.

Dis Markers. 2010;29(5):265-73. doi: 10.3233/DMA-2010-0757.

3.

ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention.

Shah SH, Hauser ER, Crosslin D, Wang L, Haynes C, Connelly J, Nelson S, Johnson J, Gadson S, Nelson CL, Seo D, Gregory S, Kraus WE, Granger CB, Goldschmidt-Clermont P, Newby LK.

Atherosclerosis. 2008 Nov;201(1):148-54. doi: 10.1016/j.atherosclerosis.2008.01.011. Epub 2008 Feb 12.

4.

[Association between 1019C/T polymorphism of Connexin 37 gene and restenosis after coronary stenting].

Yang Y, Guo SX, Yang ZY, Zhang T, Cao HM, Wang RX.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Aug;30(4):456-60. doi: 10.3760/cma.j.issn.1003-9406.2013.04.017. Chinese.

PMID:
23926016
5.

Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention.

Kullmann S, Binner P, Rackebrandt K, Huge A, Haltern G, Lankisch M, Füth R, von Hodenberg E, Bestehorn HP, Scheffold T.

BMC Cardiovasc Disord. 2009 Oct 8;9:48. doi: 10.1186/1471-2261-9-48.

6.

Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention.

Beijk MA, Boekholdt SM, Rittersma SZ, Pons D, Zwinderman AH, Doevendans PA, Tio RA, Tijssen JG, Jukema JW, de Winter RJ.

Pharmacogenet Genomics. 2010 Sep;20(9):544-52. doi: 10.1097/FPC.0b013e32833d7b29.

PMID:
20671584
7.

Systematic testing of literature reported genetic variation associated with coronary restenosis: results of the GENDER Study.

Verschuren JJ, Trompet S, Postmus I, Sampietro ML, Heijmans BT, Houwing-Duistermaat JJ, Slagboom PE, Jukema JW.

PLoS One. 2012;7(8):e42401. doi: 10.1371/journal.pone.0042401. Epub 2012 Aug 3.

8.

Pathway analysis using genome-wide association study data for coronary restenosis--a potential role for the PARVB gene.

Verschuren JJ, Trompet S, Sampietro ML, Heijmans BT, Koch W, Kastrati A, Houwing-Duistermaat JJ, Slagboom PE, Quax PH, Jukema JW.

PLoS One. 2013 Aug 9;8(8):e70676. doi: 10.1371/journal.pone.0070676. eCollection 2013.

9.

Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.

Gao J, Liu Y, Cui RZ, Mao YM, Zhou J, Chen Q, Zhao FM, Yang GM.

Chin Med J (Engl). 2013 Mar;126(6):1019-25.

PMID:
23506572
10.

Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention.

Vogiatzi K, Voudris V, Apostolakis S, Kochiadakis GE, Thomopoulou S, Zaravinos A, Spandidos DA.

Thromb Res. 2009 May;124(1):84-9. doi: 10.1016/j.thromres.2008.12.043. Epub 2009 Feb 7.

PMID:
19201454
11.

Genome-wide association study identifies a new locus for coronary artery disease on chromosome 10p11.23.

Erdmann J, Willenborg C, Nahrstaedt J, Preuss M, König IR, Baumert J, Linsel-Nitschke P, Gieger C, Tennstedt S, Belcredi P, Aherrahrou Z, Klopp N, Loley C, Stark K, Hengstenberg C, Bruse P, Freyer J, Wagner AK, Medack A, Lieb W, Grosshennig A, Sager HB, Reinhardt A, Schäfer A, Schreiber S, El Mokhtari NE, Raaz-Schrauder D, Illig T, Garlichs CD, Ekici AB, Reis A, Schrezenmeir J, Rubin D, Ziegler A, Wichmann HE, Doering A, Meisinger C, Meitinger T, Peters A, Schunkert H.

Eur Heart J. 2011 Jan;32(2):158-68. doi: 10.1093/eurheartj/ehq405. Epub 2010 Nov 18.

PMID:
21088011
12.

The C4280A (rs5705) gene polymorphism of the renin (REN) gene is associated with risk of developing coronary artery disease, but not with restenosis after coronary stenting.

Fragoso JM, Alvarez-León E, Delgadillo-Rodríguez H, Arellano-González M, López-Pacheco FC, Cruz-Robles D, Peña-Duque MA, Pérez-Méndez O, Martínez-Ríos MA, Vargas-Alarcón G.

Exp Mol Pathol. 2015 Aug;99(1):128-32. doi: 10.1016/j.yexmp.2015.06.012. Epub 2015 Jun 20.

PMID:
26102248
13.

A genome-wide association study of a coronary artery disease risk variant.

Lee JY, Lee BS, Shin DJ, Woo Park K, Shin YA, Joong Kim K, Heo L, Young Lee J, Kyoung Kim Y, Jin Kim Y, Bum Hong C, Lee SH, Yoon D, Jung Ku H, Oh IY, Kim BJ, Lee J, Park SJ, Kim J, Kawk HK, Lee JE, Park HK, Lee JE, Nam HY, Park HY, Shin C, Yokota M, Asano H, Nakatochi M, Matsubara T, Kitajima H, Yamamoto K, Kim HL, Han BG, Cho MC, Jang Y, Kim HS, Euy Park J, Lee JY.

J Hum Genet. 2013 Mar;58(3):120-6. doi: 10.1038/jhg.2012.124. Epub 2013 Jan 31.

PMID:
23364394
14.

Irrelevance of the chromosome 9p21.3 locus for acute cardiovascular events and restenosis.

Horne BD, Anderson JL.

JACC Cardiovasc Interv. 2009 Nov;2(11):1156-7. doi: 10.1016/j.jcin.2009.09.009. No abstract available.

15.

The impact of susceptibility loci for coronary artery disease on other vascular domains and recurrence risk.

Tragante V, Doevendans PA, Nathoe HM, van der Graaf Y, Spiering W, Algra A, de Borst GJ, de Bakker PI, Asselbergs FW; SMART study group..

Eur Heart J. 2013 Oct;34(37):2896-904. doi: 10.1093/eurheartj/eht222. Epub 2013 Jul 4.

PMID:
23828831
16.

Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention.

Monraats PS, Kurreeman FA, Pons D, Sewgobind VD, de Vries FR, Zwinderman AH, de Maat MP, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, Huizinga TW, Eefting D, Quax PH, Frants RR, van der Laarse A, van der Wall EE, Jukema JW.

Genes Immun. 2007 Jan;8(1):44-50. Epub 2006 Nov 23.

PMID:
17122782
17.

Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary intervention.

Vogiatzi K, Apostolakis S, Voudris V, Thomopoulou S, Kochiadakis GE, Spandidos DA.

J Thromb Thrombolysis. 2010 Jan;29(1):134-40. doi: 10.1007/s11239-009-0338-y.

PMID:
19404719
18.

Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk.

Festen EA, Stokkers PC, van Diemen CC, van Bodegraven AA, Boezen HM, Crusius BJ, Hommes DW, van der Woude CJ, Balschun T, Verspaget HW, Schreiber S, de Jong DJ, Franke A, Dijkstra G, Wijmenga C, Weersma RK.

Am J Gastroenterol. 2010 Feb;105(2):395-402. doi: 10.1038/ajg.2009.576. Epub 2009 Oct 27. Erratum in: Am J Gastroenterol. 2010 Feb;105(2):479. van der Woude, Janneke C [corrected to van der Woude, C Janneke].

PMID:
19861958
19.

9p21 is a shared susceptibility locus strongly for coronary artery disease and weakly for ischemic stroke in Chinese Han population.

Ding H, Xu Y, Wang X, Wang Q, Zhang L, Tu Y, Yan J, Wang W, Hui R, Wang CY, Wang DW.

Circ Cardiovasc Genet. 2009 Aug;2(4):338-46. doi: 10.1161/CIRCGENETICS.108.810226. Epub 2009 May 28.

20.

Genome-wide association study identifies three susceptibility loci for laryngeal squamous cell carcinoma in the Chinese population.

Wei Q, Yu D, Liu M, Wang M, Zhao M, Liu M, Jia W, Ma H, Fang J, Xu W, Chen K, Xu Z, Wang J, Tian L, Yuan H, Chang J, Hu Z, Wei L, Huang Y, Han Y, Liu J, Han D, Shen H, Yang S, Zheng H, Ji Q, Li D, Tan W, Wu C, Lin D.

Nat Genet. 2014 Oct;46(10):1110-4. doi: 10.1038/ng.3090. Epub 2014 Sep 7.

PMID:
25194280

Supplemental Content

Support Center